Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Neomycin (sulfate)

Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis[1][2].

Product Specifications

CAS Number

[1405-10-3]

UNSPSC

12352005

Hazard Statement

H317, H334

Target

Antibiotic; Bacterial; Phospholipase

Type

Natural Products

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Infection; Cancer

Assay Protocol

https://www.medchemexpress.com/Neomycin-sulfate.html

Purity

99.86

Solubility

DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 250 mg/mL (ultrasonic)

Smiles

O[C@H]1[C@H](O)[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)O[C@@H]1CN.[3H2SO4]

Molecular Formula

C23H52N6O25S3

Molecular Weight

908.88

Precautions

H317, H334

References & Citations

[1]Sasseville D. Neomycin. Dermatitis. 2010;21 (1) :3-7.|[2]Hu GF. Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci U S A. 1998;95 (17) :9791-9795.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Natural Products

Clinical Information

Launched

Isoform

Aminoglycoside

Citation 01

Adv Sci (Weinh) . 2025 Apr;12 (16) :e2415041.|Adv Sci (Weinh) . 2025 Mar 31:e2416348.|Adv Sci (Weinh) . 2025 Oct 13:e09383.|Am J Chin Med. 2024 Aug 21:1-28.|Aquaculture. 2021, 736248.|Biochem Biophys Res Commun. 2025 Jun 7:776:152161.|Biochem Pharmacol. 2024 Dec;230 (Pt 2) :116593.|Brain Behav Immun. 2021 Feb:92:102-114.|Cancer Cell. 2025 Sep 25:S1535-6108 (25) 00394-0.|Cancer Immunol Res. 2022 Dec 2;10 (12) :1542-1558.|Cancer Res. 2025 Jul 2;85 (13) :2468-2484.|Cell Biochem Biophys. 2025 Oct 31.|Cell Death Dis. 2021 Jun 7;12 (6) :582.|Cell Death Discov. 2022 Feb 22;8 (1) :77.|Cell Metab. 2023 Nov 7;35 (11) :1961-1975.e6.|Cell Metab. 2025 Jan 7;37 (1) :87-103.e10.|Cell Rep Med. 2024 Sep 21:101753.|Cell Rep. 2021 Sep 7;36 (10) :109660.|Cell Rep. 2023 Dec 27;43 (1) :113591.|Clin Transl Med. 2024 Oct;14 (10) :e70038.|CNS Neurosci Ther. 2025 Feb;31 (2) :e70253.|EMBO Rep. 2024 Nov;25 (11) :4827-4845.|Emerg Microbes Infect. 2022 Dec;11 (1) :815-828.|Exp Neurol. 2025 Jan 8:385:115142.|Food Funct. 2025 Jul 14;16 (14) :5885-5899.|Front Aging Neurosci. 2022 Jul 28;14:858130.|Gut Microbes. 2023 Dec;15 (2) :2249143.|Gut Microbes. 2023 Dec;15 (2) :2282790.|Gut Microbes. 2024 Jan-Dec;16 (1) :2390164.|Int J Biol Macromol. 2024 Sep 19:135835.|J Cell Physiol. 2022 Mar;237 (3) :1845-1856.|J Nanobiotechnology. 2024 Apr 8;22 (1) :157.|J Nanobiotechnology. 2025 Jun 13;23 (1) :443.|J Pineal Res. 2024 Apr;76 (3) :e12954.|Life Metab. 2025 Oct 8.|Life Sci. 2020 Nov 15;261:118473.|Microbiologyopen. 2019 Oct;8 (10) :e873.|Mol Cell Biochem. 2021 Jun;476 (6) :2503-2512.|Mol Immunol. 2022 Sep:149:94-106.|Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398 (4) :3681-3695.|Neurotherapeutics. 2023 Sep;20 (5) :1405-1426.|NPJ Biofilms Microbiomes. 2024 Oct 28;10 (1) :111.|Nutrients. 2023 Oct 18;15 (20) :4427.|Pharmacol Res. 2024 May 21:205:107229.|Res Sq. 2024 Oct 02.|Research (Wash D C) . 2024 Jul 16:7:0415.|Sci Adv. 2023 Feb 17;9 (7) :eade4770.|SSRN. 2023 Sep 11.|STAR Protoc. 2025 Jan 23;6 (1) :103585.|Water. 2025 Jun 6.|Adv Sci (Weinh) . 2025 Apr 28:e2409837.|Genome Biol. 2023 Apr 30;24 (1) :98.|iScience. 2025 May 13;28 (7) :112658.|iScience. 2025 May 27;28 (6) :112763.|J Agric Food Chem. 2024 Apr 10.|Neoplasia. 2024 Jan:47:100963.|Neural Regen Res. 2024 Sep 1;19 (9) :2081-2088.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Monoclonal FBXO31 Antibody (OTI1H1) [DyLight 350]
NBP2-72208UV 0.1 mL

Mouse Monoclonal FBXO31 Antibody (OTI1H1) [DyLight 350]

Ask
View Details
pCMV-SPORT6-APOA1 Plasmid
PVT31244 2 µg

pCMV-SPORT6-APOA1 Plasmid

Ask
View Details
RANKL (TNFSF11) CytoSection
TS424778P5 25 Slides

RANKL (TNFSF11) CytoSection

Ask
View Details
Leucodopachrome Hydrochloride discontinued
164743 100 mg

Leucodopachrome Hydrochloride discontinued

Ask
View Details
TRIM39, ID (TRIM39, RNF23, TFP, E3 ubiquitin-protein ligase TRIM39, RING finger protein 23, Testis-abundant finger protein, Tripartite motif-containing protein 39) (FITC) discontinued
043237-FITC 200 µL

TRIM39, ID (TRIM39, RNF23, TFP, E3 ubiquitin-protein ligase TRIM39, RING finger protein 23, Testis-abundant finger protein, Tripartite motif-containing protein 39) (FITC) discontinued

Ask
View Details